Influence of occupational exposure to antineoplastic agents on adverse pregnancy outcomes among nurses: A meta-analysis.
adverse events
nursing workforce
occupational exposure
occupational health
public health nursing
Journal
Nursing open
ISSN: 2054-1058
Titre abrégé: Nurs Open
Pays: United States
ID NLM: 101675107
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
14
02
2023
received:
16
06
2022
accepted:
09
05
2023
medline:
14
8
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
This study aimed to explore the relationship between nurses' occupational exposure to antineoplastic agents and adverse pregnancy outcomes. Meta-analysis. Data were retrieved from studies published before April 2022 in PubMed, the Cochrane Library, the Web of Science, Embase databases, the China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBM), China Science and Technology Journal databases (VIP) and Wan Fang databases (WF). Stata MP (Version 17.0) was used to conduct this meta-analysis. The current evidence shows that occupational exposure to antineoplastic agents increases nurses' risk of spontaneous abortions, stillbirths, and congenital abnormalities. It is necessary to pay attention to occupational exposures caused by antineoplastic agents, especially for female nurses of reproductive age. Managers should take timely and effective countermeasures to ensure their occupational safety and reduce the risk of adverse pregnancy outcomes.
Identifiants
pubmed: 37219069
doi: 10.1002/nop2.1853
pmc: PMC10416046
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Meta-Analysis
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5827-5837Informations de copyright
© 2023 The Authors. Nursing Open published by John Wiley & Sons Ltd.
Références
J Epidemiol Community Health. 1985 Jun;39(2):141-7
pubmed: 3925060
J Oncol Pharm Pract. 2005 Jun;11(2):69-78
pubmed: 16465719
BMC Health Serv Res. 2020 Jun 24;20(1):577
pubmed: 32580775
Regul Toxicol Pharmacol. 2002 Jun;35(3):448-67
pubmed: 12202058
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):626-50
pubmed: 22851372
J Womens Health (Larchmt). 2010 Oct;19(10):1851-62
pubmed: 20809857
CA Cancer J Clin. 2006 Nov-Dec;56(6):354-65
pubmed: 17135692
Ann Epidemiol. 2021 Jan;53:95-102.e2
pubmed: 32920100
NTP Monogr. 2019 Mar;(5):
pubmed: 33556047
Int Arch Occup Environ Health. 2021 Nov;94(8):1839-1850
pubmed: 34021808
Nurs Open. 2023 Sep;10(9):5827-5837
pubmed: 37219069
BMC Pharmacol Toxicol. 2019 Dec 2;20(1):74
pubmed: 31791417
Am J Obstet Gynecol. 2012 Apr;206(4):327.e1-8
pubmed: 22304790
J Occup Environ Med. 2014 Sep;56(9):901-10
pubmed: 25153300
Br J Ind Med. 1992 Dec;49(12):855-61
pubmed: 1472444
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
AAOHN J. 1993 Mar;41(3):110-9
pubmed: 8476440
Scand J Work Environ Health. 1990 Apr;16(2):102-7
pubmed: 2353192
Toxicol Lett. 2012 Aug 13;213(1):107-15
pubmed: 21477641
Drug Discov Today. 2016 Jul;21(7):1046-50
pubmed: 27109618
N Engl J Med. 1985 Nov 7;313(19):1173-8
pubmed: 4058490
Sci Total Environ. 2021 Dec 15;800:149412
pubmed: 34391154
Workplace Health Saf. 2017 Jan;65(1):9-20
pubmed: 27758934
Int J Pharm Pract. 2020 Oct;28(5):506-511
pubmed: 31663186